Annual reporting suite
Access and download our annual regulatory filings and other reporting documents.
You can order the publications here.
Other reporting documents
Update on Public Commitments 2025
Outlines the progress made toward our social impact and sustainability targets and aspirations.
Download the Update (PDF 0.3 MB)
ESG Data Summary 2025
Nonfinancial performance metrics in the Report on Nonfinancial Matters 2025, the Update on Public Commitments 2025 and data supporting information on our website.
Download the Summary (PDF 0.3 MB) | Spreadsheet (ZIP 32 KB)
Sustainability Accounting Standards Board (SASB) index
A summary of our alignment with SASB's Biotechnology & Pharmaceuticals Sustainability Accounting Standard across different disclosures.
Download the SASB index (PDF 0.2 MB)
Investor relations
Policies and positions
As part of our ongoing commitment to transparency, we publish our positions on various issues affecting our business. We are also transparent about our values and behaviors, our approach to managing ethical decisions, and the standards we expect of our suppliers. This section includes many of the policies, codes, guidelines and commitments that govern the company's activities.
Positions
- Animal research (PDF 0.2 MB)
- Clinical study transparency (PDF 0.2 MB)
- Medicines for Patients with Rare Diseases (PDF 0.2 MB)
- Post-trial Access (PDF 0.1 MB)
- Novartis Position on Access to Unauthorized Novartis Products through Managed Access Programs (MAPs) (PDF 0.2 MB)
- Responsible Clinical Trials (PDF 0.1 MB)
- Novartis Commitment to Diversity in Clinical Trials (PDF 0.2 MB)
- Novartis Position on Investigator Initiated Trials (IITs) and Investigator Initiated Research (IIRs) (PDF 0.2 MB)
- Position on Scientific Publications (PDF 0.2 MB)
Codes, Policies and Guidelines
- Novartis Third Party Code v. 1.0 (PDF 0.6 MB)*
- Novartis Third Party Code v. 2.0 (PDF 0.3 MB)**
- Novartis Third Party Code v. 3.0 (PDF 0.4 MB)***
- Novartis Third Party Code v. 4.0 (PDF 0.5 MB)****
- Novartis Minimum Information Security Controls for Suppliers (PDF 0.5 MB)
- Novartis No Purchase Order (PO) No Pay Policy (PDF 0.1 MB)
* v1.0 remains valid for contracts entered into up to October 31, 2020 unless the contract stipulates that the most up-to-date TPC version is to be adhered to.
** v2.0 remains valid for contracts entered into up to December 31, 2022 unless the contract stipulates that the most up-to-date TPC version is to be adhered to.
*** v3.0 remains valid for contracts entered into up to June 30, 2025 unless the contract stipulates that the most up-to-date TPC version is to be adhered to.
**** v4.0 is valid for contracts entered into as from July 1, 2025